Efficacy and safety of liraglutide versus placebo as add-on to glucose-lowering therapy in patients with type 2 diabetes and moderate renal impairment (LIRA-RENAL): a randomized clinical trial
Other GLP1 receptor agonists, such as Trulicity (dulaglutide), Wegovy (also semaglutide but at a higher dose for weight loss), and Victoza (liraglutide), offer similar mechanisms but vary in dosing frequency, cost, and clinical indications
The process can take 1-2 weeks and may require documentation of: Your current BMI and weight Previous weight loss attempts and their outcomes Weight-related health conditions (diabetes, hypertension, sleep apnea, etc.) Why this specific medication is medically necessary A supportive doctors office makes this process much smoother by providing thorough documentation and following up with insurance companies on your behalf
We have good data that suddenly stopping the medication leads to weight regain in the majority of people, says Kushner
Historically, state Medicaid programs, state employee health plans and a myriad of other insurers have provided coverage of GLP-1s to treat Type 2 Diabetes
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes and, in some formulations, to support weight management
